MarketFriction

Sanofi Consumer Healthcare India Ltd

NSE SANOFICONR · BSE 544250 · Pharmaceuticals
₹3,787.20 -0.41%
NSE close2026-10-01
52 week range3,796.00 - 5,255.00
Market cap₹8,906 Cr.
P/E33.5
Price band 20% Delivery 53.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales210225222172160171173221234251229236
Expenses11613514010997109109151149161140146
Operating Profit959082646362647085908989
OPM %45%40%37%37%39%36%37%32%36%36%39%38%
Other Income113-24325123566
Interest000030001000
Depreciation111121233333
Profit before tax959084396163677984909192
Tax %25%24%25%25%26%29%25%23%25%27%25%25%
Net Profit716863294544506163666869
EPS in Rs12.5919.5419.2421.7126.3627.3128.8729.4429.87
Dec 2023 8mDec 2024Mar 2025Dec 2025TTM
Sales555724878878950
Expenses337454569569597
Operating Profit219271309309353
OPM %39%37%35%35%37%
Other Income2-15252520
Interest04222
Depreciation24121213
Profit before tax219247320320357
Tax %25%27%25%25%
Net Profit165181240240266
EPS in Rs78.59104.25104.25115.49
Dividend Payout %6%70%0%72%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%31%
Compounded Profit Growth%%%34%
Stock Price CAGR%%%-18%
Return on Equity%%78%72%
Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital2232323
Reserves206250361325
Borrowings0202521
Other Liabilities138138138338
Total Liabilities345431547706
Fixed Assets5293630
CWIP3100
Investments0000
Other Assets338402511677
Total Assets345431547706
Dec 2023Dec 2024Mar 2025Dec 2025
Cash from Operating Activity-0439175
Cash from Investing Activity028
Cash from Financing Activity2-116-134
Net Cash Flow232548
Free Cash Flow-4429167
CFO/OP2%208%85%
Dec 2023Dec 2024Mar 2025Dec 2025
Debtor Days21712
Inventory Days2328098
Days Payable144138126
Cash Conversion Cycle109-51-16
Working Capital Days134-33-4
ROCE %111%90%
Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters60.40%60.40%60.40%60.40%71.27%71.27%71.27%71.27%71.27%
FIIs6.03%5.22%4.42%4.52%3.24%2.94%2.83%2.76%2.60%
DIIs22.60%23.83%25.35%25.48%16.89%17.21%17.33%17.57%17.85%
Public10.98%10.56%9.84%9.59%8.59%8.58%8.57%8.41%8.28%
No. of Shareholders61,09158,58255,73451,85949,63248,80848,07548,41847,511

Fundamentals

Market Cap₹ 8,906 Cr.
Current Price₹ 3,867
Stock P/E33.5
Book Value₹ 151
ROCE89.9 %
ROE71.6 %
Dividend Yield1.94 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)31%
Compounded Profit Growth (TTM)34%
Standalone figures.
Ownership
Promoter holding71.27% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodSANOFICONRNifty 50Difference
1 week-4.6%-2.8% -1.9 pts
1 month-8.5%-6.8% -1.7 pts
3 months-18.1%-7.6% -10.5 pts
6 months-11.9%+0.4% -12.3 pts
1 year-22.7%-9.9% -12.8 pts
2 years-25.6%-13.6% -12.0 pts
42 mutual fund schemes hold about ₹1,306 Cr. Over three months 19 bought more and 7 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India Growth Mid Cap Fund0.35%183 +10%
Aditya Birla SL Large Cap Fund0.47%141 +7%
Nippon India Small Cap Fund0.14%113 +5%
Nippon India Multi Cap Fund0.20%113 +95%
Nippon India Pharma Fund0.93%88 +5%
ICICI Pru Small Cap Fund0.77%76 +5%
ICICI Pru Small Cap Fund0.77%73 +5%
SBI Dividend Yield Fund0.85%73 +1%
ICICI Pru Healthcare Fund-0.97%68 +4%
Sundaram Small Cap Fund1.15%48 +2%
Aditya Birla SL Small Cap Fund0.77%48 +1%
Nippon India Innovation Fund1.29%40 +30%
Aditya Birla SL Consumption Fund0.53%32 +8%
Nippon India Multi Asset Allocation Fund0.18%32 -2%
Abakkus Small Cap Fund1.06%30 -6%
Aditya Birla SL Aggressive Hybrid Fund0.36%26 +8%
Aditya Birla SL MNC Fund0.62%21 +8%
UTI Dividend Yield Fund0.46%17 +9%
ICICI Pru Bharat Consumption Fund0.44%14 +7%
Aditya Birla SL Pharma & Healthcare Fund1.19%13 +1%
Baroda BNP Paribas Value Fund1.08%11 +13%
UTI Healthcare Fund0.69%10 -0%
Tata India Pharma & Healthcare Fund0.53%8 +100%
Motilal Oswal Nifty Microcap 250 Index Fund0.28%7 +3%
Baroda BNP Paribas Business Conglomerates Fund1.04%7 +12%

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹236 Cr +6.8% vs Jun 2025. Net profit ₹69 Cr +13.1%.
Against our estimate for Jun 2026: sales -23.5%, profit -17.9% miss. Our estimate for Sep 2026: sales Rs 280 Cr, profit Rs 79 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-06-19Dividend - Rs 75 Per Share
2025-04-17Dividend - Rs 55 Per Share
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Sanofi Consumer Healthcare India Ltd?

Sanofi Consumer Healthcare India Ltd (SANOFICONR) has a market capitalisation of Rs 8,906 Cr. at the 2026-10-01 close.

What is the P/E ratio of Sanofi Consumer Healthcare India Ltd?

Sanofi Consumer Healthcare India Ltd trades at a P/E of 33.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were Sanofi Consumer Healthcare India Ltd's latest quarterly results?

In the Jun 2026 quarter, Sanofi Consumer Healthcare India Ltd sales was Rs 236 Cr (+6.8% vs Jun 2025) and net profit was Rs 69 Cr.

What is the 52-week high and low of Sanofi Consumer Healthcare India Ltd?

The 52-week high is Rs 5,255.00 and the 52-week low is Rs 3,796.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03